MDedge Cardiocast
MDedge Cardiocast
MDedge
New LDL-lowering drug is under FDA review
6 minutes Posted Mar 15, 2019 at 8:00 am.
0:00
6:21
Download MP3
Show notes

This week in MDedge Cardiocast: A novel drug lowers LDL in on top of maximums statins, invasive cardiology is a top money maker for hospitals, a meta-analysis parses the heart and kidney benefits of new diabetes drugs, and the AHA warns that heart-harming toxins may hurt hookah smokers.